Notably, alterations in D2 dopamine receptor expression and signaling were consistently reported in psychiatric disorders and are relevant for pharmacological treatments (Ralph-Williams et al., 2002; Papaleo et al., 2012a; Ripke et al., 2013). The gene discussed is DRD2; the disease is psychiatric disorder.